Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Recruiting · NCT05841758 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Recruiting | Phase 4 | 2026-09-17 | NCT05841758 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospices Civils de Lyon | 429 |
21 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.